Background. Previous experimental studies have shown that the effect of serotonin on a coronary stenosis depends on whether that stenosis is compliant or fixed. However, the relation between coronary stenosis morphology and the response to serotonin in patients with angina is not known.
E vidence suggests that the obstruction associated with a coronary artery stenosis is often dynamic rather than fixed.' A 10% circumferential shortening of the normal wall may lead to a greater change in luminal caliber at the site of an eccentric plaque than at the site of a concentric plaque.23 Fur- thermore, coronary stenosis morphology may be an important factor determining the degree of vasomotor response to stimulation.4 Previous studies in animals have shown that the intracoronary activation of platelets may contribute to or cause myocardial ischemia both by causing mechanical obstruction of the arterial lumen and by releasing potent vasoconstrictor substances such as serotonin,5-13 and recent studies support a role for these mechanisms in humans.14-17 Experimental studies '8 show that the effects of serotonin differ depending on whether the stenosis is compliant or fixed. There is little information, however, on the relation between coronary stenosis morphology and the vasomo-tor response to serotonin in patients with angina syndromes.
To study the vasomotor effects of serotonin and their relation to coronary stenosis morphology, we used quantitative angiography to examine the effect of intracoronary serotonin infusion on coronary luminal diameter at the site of concentric, eccentric, and complicated lesions in patients with chronic stable angina and patients with variant angina.
Methods

Patients
Fifteen patients admitted for routine cardiac catheterization were studied. The study protocol was approved by the Research Ethics Committee of the Hammersmith Hospital, and written informed consent was obtained from all patients. Regular medication for angina was discontinued at least 24 hours before catheterization. All patients continued to take aspirin (100 to 300 mg/d). Patients were allowed to use sublingual nitroglycerin as needed, but no study was performed within 3 hours of its administration.
Eleven patients (8 Two ECG leads were monitored continuously throughout the study. Femoral arterial pressure, heart rate, and two ECG leads were recorded during the last 30 seconds of each infusion period. After the diagnostic study, an optimal radiographic projection was chosen to visualize the coronary artery to be studied, and the position of the image intensifier was subsequently kept constant. Heparin was not routinely administered. The artery studied was chosen to comply with the Research Ethics Committee's requirements that severe stenoses (>80% reduction in diameter) be avoided. Ten left and five right coronary arteries were studied. In four patients, the infused artery supplied collaterals to an occluded vessel. In the patients with variant angina, the infused artery was that corresponding to the ischemic territory on ergonovine testing assessed by the ECG changes.
All infusions were administered through 8F Judkins catheters at room temperature at a rate of 1 mL/min with a syringe pump (Perfusor, Braun-Melsungen). We have previously shown that random fluctuations in coronary luminal diameter or systematic changes caused by repeated infusions of saline or injections of contrast medium are insignificant.'4 The patients therefore received a single 2-minute infusion of vehicle solution (0.9% saline) followed by 2-minute infusions of serotonin of increasing concentrations from 10-7 to 10-4 mol/L followed by an intracoronary bolus dose of isosorbide dinitrate (2 mg in 2 mL of saline) (Fig 1) . Angiography was performed with a hand injection of 6 to 8 mL nonionic contrast at baseline, after each infusion, and after isosorbide dinitrate (Fig 1) 
Quantitative Coronary Angiography
The arterial segments in each frame were analyzed in random order by quantitative computerized analysis with an automated edge contour detection analysis system (Computerized Angiographic Analysis System [CAAS], Version 2V2; Pie Data Medical).'9 End-diastolic frames from each arteriogram were selected for analysis. The angiographic catheter was used as a scaling device, and this, together with the pincushion-distortion correction, allowed the diameters to be recorded as absolute values (expressed in millimeters). All major coronary arteries were divided into thirds according to the American Heart Association classification,20 and for the purpose of the study, angiographicaily normal segments located in the proximal and distal thirds (removed from all stenoses) were analyzed. Recorded variables at baseline and after saline, serotonin, and nitrate administration were (1) the diameter of angiographically normal proximal and distal segments; (2) the location of stenoses, defined as the site of minimal lumen diameter relative to side branch origins (Table 1) ; (3) the minimum diameter of stenoses in millimeters; (4) minimum luminal diameter in millimeters of the reference segment just proximal to the stenosis ( Fig  2) ; and (5) Fig 3) . For complicated stenoses, the magnitude of constriction (diameter at baseline minus diameter after serotonin) was greater than that of the reference segments (0.85+±0.16 versus 0.42±0.12 mm, respectively; P<.05), whereas it was similar to that of reference segments for concentric (0.25+±0.05 versus 0.27±0.06 mm, respectively; P=NS) and eccentric (0.57+0.13 versus 0.39±0.14 mm, respectively; P=NS) stenoses (Fig 4) . The severity of the 38 stenoses at baseline did not correlate with the magnitude of vasoconstriction induced by serotonin irrespective of the type of morphology (Fig 5) , whereas there was a weak correlation (r=.39, P<.05) between the length of stenoses and the magnitude of vasoconstriction (Fig 6) Fig 3) . A larger proportion of eccentric than of either concentric or complicated stenoses showed dynamic behavior (>20% increase from baseline) ( Irregular (complicated) stenoses showed a significantly greater reduction in caliber after intracoronary serotonin than smooth lesions (concentric and eccentric) both in patients with stable angina (51.8±7.3% versus 22.5+±4.1%) and in patients with variant angina (77.3±17% versus 28.2±8.1%) (Fig 7) . The stenosis reactivity was independent of eccentricity ratio both in stable angina and in variant angina. In stable angina, 16 stenoses with a concentric ratio and 13 stenoses with an eccentric ratio developed similar caliber reduction in response to serotonin (29.07+6.5% versus 36.96+5.8%, P=NS). Furthermore, in variant angina, 4 stenoses with a concentric ratio and 5 stenoses with an eccentric ratio developed similar caliber reduction in response to serotonin (36.7±18% versus 50.8+14%, P=NS).
Discussion
The results of this study show that complicated coronary stenoses are more likely to constrict significantly and to a greater degree in response to serotonin than eccentric and concentric stenoses in both patients with chronic stable angina and those with variant angina. Furthermore, the enhanced constriction is focal at the site of the stenosis, as indicated by the results showing a larger change in luminal diameter at the site of the stenosis than at the adjacent reference arterial segment. The degree of enhanced constriction is only weakly related to stenosis length and is unrelated to baseline minimum luminal diameter. Eccentric In a large proportion of patients with acute coronary syndromes, evidence of enhanced vasoconstriction at the site of stenosis has been reported34 and could be explained by the effect of locally released serotonin on vascular smooth muscle receptors in the presence of diseased endothelium.
Clinical Implications
The presence of eccentric or complicated atheromatous plaques even without severe luminal stenosis could, caused by changes in functional receptor density, particularly of 5-HT, and 5-HT2 subtypes, explain the variation in effort tolerance seen in some patients with chronic stable angina and also the attacks of angina at rest seen in patients with unstable angina. The detection of such plaques may therefore provide prognostic information and also assist in identifying patients likely to benefit from coronary vasodilator drugs (Fig 2) . Furthermore, specific constrictor receptor blocking agents might be expected to have a greater beneficial effect in patients with such lesions. They could prevent the progression of such complicated plaques to occlusion in acute myocardial infarction and unstable angina, in which preexisting lesions may not be associated with severe stenoses. 35 More detailed in vivo studies of plaque morphology and tissue characterization are required using newer techiques such as angioscopy and coronary ultrasound imaging to further elucidate their relation to the density of receptors mediating coronary vasomotor responses. Conclusions
In patients with chronic stable angina and with variant angina, the magnitude of the vasoconstrictor response to serotonin at the site of an atheromatous coronary plaque depends on the morphological characteristics of the plaque, particularly irregularity, and is independent of stenosis severity. This relation suggests that variations in receptor type and density or in the smooth muscle cell response to stimulation may determine the clinical manifestations of coronary disease.
